2022
AgRP neurons control structure and function of the medial prefrontal cortex
Stutz B, Waterson MJ, Šestan-Peša M, Dietrich MO, Škarica M, Sestan N, Racz B, Magyar A, Sotonyi P, Liu ZW, Gao XB, Matyas F, Stoiljkovic M, Horvath TL. AgRP neurons control structure and function of the medial prefrontal cortex. Molecular Psychiatry 2022, 27: 3951-3960. PMID: 35906488, PMCID: PMC9891653, DOI: 10.1038/s41380-022-01691-8.Peer-Reviewed Original ResearchConceptsMedial prefrontal cortexAgRP neuronsNon-selective dopamine receptor antagonistBrain functionPrefrontal cortexHypothalamic AgRP neuronsMedial thalamic neuronsAdministration of clozapineDopamine receptor antagonistVentral tegmental areaOscillatory network activityHigher-order brain functionsHypothalamic agoutiThalamic neuronsChemogenetic inhibitionDopaminergic neuronsReceptor antagonistTegmental areaNeuronal pathwaysSensorimotor gatingAdult miceModulatory impactAmbulatory behaviorConstitutive impairmentNeurons
2011
Modulation of Inflammatory Responses by a Cannabinoid-2–Selective Agonist after Spinal Cord Injury
Adhikary S, Li H, Heller J, Skarica M, Zhang M, Ganea D, Tuma R. Modulation of Inflammatory Responses by a Cannabinoid-2–Selective Agonist after Spinal Cord Injury. Journal Of Neurotrauma 2011, 28: 2417-2427. PMID: 21970496, PMCID: PMC3235339, DOI: 10.1089/neu.2011.1853.Peer-Reviewed Original ResearchConceptsSpinal cord injuryInflammatory responseSpinal cordSelective CB2 agonistAutonomic functionCord injuryMotor functionCB2 agonistsToll-like receptor expressionChemokine/cytokine expressionIL-23p19 expressionCell invasionInflammatory cell invasionSignificant reductionContusion injuryPercentage of animalsCXCL-9Immunoreactive microgliaCXCL-11Cytokine expressionIL-23RReceptor expressionInflammatory reactionInjuryEntire study period
2010
Dendritic Cells Transduced With Lentiviral Vectors Expressing VIP Differentiate Into VIP-secreting Tolerogenic-like DCs
Toscano M, Delgado M, Kong W, Martin F, Skarica M, Ganea D. Dendritic Cells Transduced With Lentiviral Vectors Expressing VIP Differentiate Into VIP-secreting Tolerogenic-like DCs. Molecular Therapy 2010, 18: 1035-1045. PMID: 20068554, PMCID: PMC2890107, DOI: 10.1038/mt.2009.293.Peer-Reviewed Original ResearchMeSH KeywordsAnimalsBone Marrow CellsCell DifferentiationCell MovementCells, CulturedDendritic CellsEnzyme-Linked Immunosorbent AssayFlow CytometryGenetic VectorsLentivirusMiceMice, Inbred BALB CPolymerase Chain ReactionReverse Transcriptase Polymerase Chain ReactionTransduction, GeneticVasoactive Intestinal PeptideConceptsVasoactive intestinal peptideExperimental autoimmune encephalomyelitisDendritic cellsTherapeutic effectTolerogenic DCsVIP administrationInflammatory disordersT cellsImmune responseBone marrow-derived dendritic cellsBone marrow-derived DCsMarrow-derived dendritic cellsNeuropeptide vasoactive intestinal peptideTolerogenic dendritic cellsAllogeneic T cellsAutoimmune/inflammatory disordersRegulatory T cellsIL-10 productionProinflammatory cytokine secretionPromising therapeutic toolLentiviral vectorsHigh-dose inoculationCLP miceAutoimmune encephalomyelitisPuncture (CLP) sepsis
2009
Cyclophosphamide resets dendritic cell homeostasis and enhances antitumor immunity through effects that extend beyond regulatory T cell elimination
Radojcic V, Bezak K, Skarica M, Pletneva M, Yoshimura K, Schulick R, Luznik L. Cyclophosphamide resets dendritic cell homeostasis and enhances antitumor immunity through effects that extend beyond regulatory T cell elimination. Cancer Immunology, Immunotherapy 2009, 59: 137-148. PMID: 19590872, PMCID: PMC3103867, DOI: 10.1007/s00262-009-0734-3.Peer-Reviewed Original ResearchConceptsDendritic cell homeostasisAntitumor immunityT cellsLow-dose total body irradiationTumor antigen-specific T cellsAnti-CD25 monoclonal antibodyHematopoietic stem cell supportAntigen-specific T cellsUntreated tumor-bearing animalsTumor-infiltrating DCsExpansion of TregsRegulatory T cellsStem cell supportTotal body irradiationT cell responsesLess IL-10More IL-12Tumor-bearing animalsT cell eliminationCell homeostasisDC turnoverTreg depletionImmunotherapeutic strategiesIL-10Body irradiationSignal Transduction Inhibition of APCs Diminishes Th17 and Th1 Responses in Experimental Autoimmune Encephalomyelitis
Skarica M, Wang T, McCadden E, Kardian D, Calabresi P, Small D, Whartenby K. Signal Transduction Inhibition of APCs Diminishes Th17 and Th1 Responses in Experimental Autoimmune Encephalomyelitis. The Journal Of Immunology 2009, 182: 4192-4199. PMID: 19299717, PMCID: PMC3727416, DOI: 10.4049/jimmunol.0803631.Peer-Reviewed Original ResearchConceptsExperimental autoimmune encephalomyelitisPeripheral dendritic cellsDendritic cellsT cellsSignal transduction inhibitorsAutoimmune encephalomyelitisMultiple sclerosisIFN-gamma-secreting T cellsBone marrow chimera systemAg-specific T cellsTransduction inhibitorsT cell responsesT cell subsetsSignal transduction inhibitionCNS infiltrationCytokine polarizationIL-17IL-23Th1 responseAutoimmune responseCell subsetsCostimulatory moleculesIL-6TNF-alphaCEP-701
2007
Factors governing the activation of adoptively transferred donor T cells infused after allogeneic bone marrow transplantation in the mouse
Durakovic N, Radojcic V, Skarica M, Bezak K, Powell J, Fuchs E, Luznik L. Factors governing the activation of adoptively transferred donor T cells infused after allogeneic bone marrow transplantation in the mouse. Blood 2007, 109: 4564-4574. PMID: 17227829, PMCID: PMC1885486, DOI: 10.1182/blood-2006-09-048124.Peer-Reviewed Original ResearchConceptsDonor lymphocyte infusionDonor T cellsHost T cellsBone marrow transplantationT cellsHost chimerismHost APCsMarrow transplantationPrevious sensitizationAllogeneic bone marrow transplantationToll-like receptor ligandsGvH responseGVL reactivityLeukemia reactivityLymphocyte infusionMixed chimerismTLR ligandsHost antigensMurine modelVivo administrationCell activatorsHigh levelsAlloreactivityChimerismMHC
2006
Host-Derived Langerhans Cells Persist after MHC-Matched Allografting Independent of Donor T Cells and Critically Influence the Alloresponses Mediated by Donor Lymphocyte Infusions
Durakovic N, Bezak K, Skarica M, Radojcic V, Fuchs E, Murphy G, Luznik L. Host-Derived Langerhans Cells Persist after MHC-Matched Allografting Independent of Donor T Cells and Critically Influence the Alloresponses Mediated by Donor Lymphocyte Infusions. The Journal Of Immunology 2006, 177: 4414-4425. PMID: 16982876, DOI: 10.4049/jimmunol.177.7.4414.Peer-Reviewed Original ResearchConceptsCutaneous lymph nodesDonor lymphocyte infusionDonor T cellsBone marrow transplantationLangerhans cellsLymphocyte infusionMarrow transplantationCell reconstitutionT cellsDendritic cell reconstitutionDonor-derived DCsHost Langerhans cellsSplenic DC subsetsTLR7 ligand imiquimodMinor histocompatibility AgT-cell reconstitutionDLI administrationHost alloresponsesHost DCsLC emigrationDC subsetsLymph nodesCostimulatory moleculesHistocompatibility AgCells persistInterferon-producing killer dendritic cells provide a link between innate and adaptive immunity
Chan C, Crafton E, Fan H, Flook J, Yoshimura K, Skarica M, Brockstedt D, Dubensky T, Stins M, Lanier L, Pardoll D, Housseau F. Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity. Nature Medicine 2006, 12: 207-213. PMID: 16444266, DOI: 10.1038/nm1352.Peer-Reviewed Original ResearchMeSH KeywordsAdaptation, PhysiologicalAnimalsAntigen PresentationCell Line, TumorCytotoxicity, ImmunologicDendritic CellsGene ExpressionImmunity, InnateIn Vitro TechniquesInterferonsKiller Cells, NaturalListeria monocytogenesMiceMice, Inbred BALB CMice, Inbred C57BLMice, Inbred DBAMice, KnockoutMice, TransgenicOligodeoxyribonucleotidesConceptsInterferon-producing killer dendritic cellsDendritic cellsKiller dendritic cellsI interferonNK cellsAdaptive immunityAntigen-presenting cell activityMajor histocompatibility complex class IISurface major histocompatibility complex class IIHistocompatibility complex class IIClassical NK cellsPlasmacytoid dendritic cellsTarget cellsAntigen-presenting activityConventional dendritic cellsNatural killer cellsNK target cellsToll-like receptorsType I interferonNK functionLymph nodesNKG2D receptorKiller cellsCostimulatory moleculesCytolytic capacity